In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://deborahxugf942912.activoblog.com/44649904/hc-confirms-government-sanction-for-risdiplam-in-india